Table 2.
2006 (N = 18,507) | 2009 (N = 20,744) | p-value | ||
---|---|---|---|---|
Demographic information | Male sex | 9797 (53) | 10,948 (53) | 0.818 |
Age (yr) | 66.1 ± 13.7 | 67.8 ± 13.8 | <0.001 | |
Antidiabetic therapy | Metformin | 2893 (16) | 6989 (34) | <0.001 |
Other hypoglycaemic agent | 413 (2) | 1348 (6) | <0.001 | |
Insulin (or analogue) | 1994 (11) | 3099 (15) | <0.001 | |
Any in the category | 4771 (26) | 9762 (47) | <0.001 | |
Additional therapy | Statin | 4040 (22) | 7202 (35) | <0.001 |
Acetylsalicylic acid or other platelet aggregation inhibitor | 4951 (27) | 7974 (38) | <0.001 | |
Renin-angiotensin system modifier | 8255 (45) | 11,815 (57) | <0.001 | |
Any in the category | 10,097 (55) | 14,610 (70) | <0.001 |
aNumber (percentage) or mean ± SD reported